Effect of BG-12 (Dimethyl Fumarate) in Subgroups of Patients with Relapsing-Remitting Multiple Sclerosis: Findings from Two Phase 3 Studies (DEFINE and CONFIRM)

被引：0

作者：

Hutchinson, M. ^{[1
]}

Bar-Or, A. ^{[2
]}

Fox, R. J. ^{[3
]}

Gold, R. ^{[4
]}

Giovannoni, G. ^{[5
]}

Kita, M. ^{[6
]}

O'Gorman, J. ^{[7
]}

Yang, M. ^{[7
]}

Sheikh, S. I. ^{[7
]}

Viglietta, V. ^{[7
]}

Dawson, K. T. ^{[7
]}

机构：

[1] St Vincents Univ Hosp, Dublin 4, Ireland

[2] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada

[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA

[4] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany

[5] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England

[6] Virginia Mason Med Ctr, Seattle, WA 98101 USA

[7] Biogen Idec Inc, Weston, MA USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：682 / 683

页数：2

共 50 条

[21] Safety and tolerability of BG-12 in patients with relapsing-remitting multiple sclerosis: results from the phase 3 CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
Havrdova, E.
Phillips, J. T.
Fox, R. J.
Miller, D.
Kita, M.
Hutchinson, M.
Raghupathi, K.
Yuan, H.
Novas, M.
Sweetser, M. T.
Viglietta, V.
Dawson, K. T.
JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S105
[22] Clinical efficacy of BG-12 in relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies
Gold, R.
Miller, D. H.
Phillips, J. T.
Arnold, D. L.
Selmaj, K.
Yang, M.
Zhang, R.
Dawson, K. T.
Viglietta, V.
Sheikh, S. I.
Fox, R. J.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 48 - 49
[23] Clinical Efficacy of BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis (RRMS) According to Prior Therapy: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
Hutchinson, Michael
Gold, Ralf
Fox, Robert
Havrdova, Eva
Giovannoni, Gavin
Zhang, Annie
Hotermans, Christophe
Stephan, Monica
Dawson, Katherine
Bar-Or, Amit
NEUROLOGY, 2013, 80
[24] Efficacy of Oral BG-12 (Dimethyl Fumarate) in Patients Newly Diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Analysis of DEFINE and CONFIRM
Gold, R.
Giovannoni, G.
Phillips, J. T.
Fox, R. J.
Rana, J.
Zhang, A.
Meltzer, L.
Kurukulasuriya, N. C.
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 931 - 932
[25] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study
Hutchinson, Michael
Fox, Robert J.
Miller, David H.
Phillips, J. Theodore
Kita, Mariko
Havrdova, Eva
O'Gorman, John
Zhang, Ray
Novas, Mark
Viglietta, Vissia
Dawson, Katherine T.
JOURNAL OF NEUROLOGY, 2013, 260 (09) : 2286 - 2296
[26] Effect of BG-12 on magnetic resonance imaging activity in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study
Miller, D. H.
Hutchinson, M.
Fox, R. J.
Phillips, J. T.
Kita, M.
Havrdova, E.
O'Gorman, J.
Yang, M.
Viglietta, V.
Dawson, K. T.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 189 - 190
[27] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study
Bar-Or, Amit
Gold, Ralf
Kappos, Ludwig
Arnold, Douglas L.
Giovannoni, Gavin
Selmaj, Krzysztof
O'Gorman, John
Stephan, Monica
Dawson, Katherine T.
JOURNAL OF NEUROLOGY, 2013, 260 (09) : 2297 - 2305
[28] Timecourse of Treatment Effects of BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis
Kappos, Ludwig
Giovannoni, Gavin
Gold, Ralf
Fox, Robert
Phillips, J. Theodore
Hotermans, Christophe
Zhang, Annie
Viglietta, Vissia
Miller, David
NEUROLOGY, 2013, 80
[29] Effect of BG-12 on magnetic resonance imaging activity in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the DEFINE study
Bar-Or, A.
Gold, R.
Kappos, L.
Arnold, D. L.
Giovannoni, G.
Selmaj, K.
O'Gorman, J.
Stephan, M.
Dawson, K. T.
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 356 - 356
[30] Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study
Kita, Mariko
Fox, Robert J.
Phillips, J. Theodore
Hutchinson, Michael
Havrdova, Eva
Sarda, Sujata P.
Agarwal, Sonalee
Kong, Jessica
Zhang, Annie
Viglietta, Vissia
Sheikh, Sarah I.
Seidman, Emily
Dawson, Katherine T.
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (02) : 253 - 257

← 1 2 3 4 5 →